CHX+ADS: Anti-staining Efficacy of Anti-Discoloration System (ADS) Added to Chlorhexidine (CHX)

Sponsor
University of Milan (Other)
Overall Status
Completed
CT.gov ID
NCT02709824
Collaborator
(none)
22
1
2
7
3.1

Study Details

Study Description

Brief Summary

Dental staining is the most common local side effect of chlorhexidine (CHX) mouthwashes.

A prospective, cross-over, randomized clinical trial will be carried out in triple blind to compare the effect on dental staining of two 0.12% CHX mouthwashes: with or without anti-discoloration system (ADS). Twenty-two healthy subjects will be enrolled. Briefly, the study includes two sequential stages: in the first phase, the "immediate" objective and subjective evaluation of dental discoloration by spectroscopic and questionnaire-based analyses will be recorded, at baselines and after each 21-days-long cycle of mouthwash. A wash-out period between the cycles of 21 days will be performed.

In the second phase, a long-term (after 6 months) subjective evaluation of dental discoloration will be obtained by means of clinical photograph visual analysis and new questionnaires.

Condition or Disease Intervention/Treatment Phase
  • Drug: Chlorhexidine gluconate with ADS
  • Drug: Chlorhexidine gluconate without ADS
N/A

Detailed Description

In the first phase, the "immediate" objective and subjective evaluation of dental discoloration by spectroscopic (CIE Lab* data analysis with DeltaE evaluation) and questionnaire-based analyses will be recorded. Immediate visual analysis of tooth pigmentation will be evaluated by volunteer him/herself, using a mirror, and by a single dentist soon after the end of each treatment. Participants will indicate the presence/absence of dental pigmentation, and to quantify it with a numeric scale (0= no pigmentation to 10= very strong pigmentation).

These analyses will be performed at baselines and after each 21-days-long cycle of mouthwash.

A wash-out period between the cycles of 21 days will be performed. In the second "late" phase, a long-term subjective evaluation of dental discoloration will be obtained by means of the visual analysis of clinical photograph and new questionnaires. After 6 months from clinical trial (second stage of the study), frontal dental images of volunteers, collected during the first phase, will be printed on photographic paper and, then, visually analyzed, in blind, by the 22 volunteers themselves, as well as by 14 dentists and 13 oral hygienists ad hoc recruited. Dentists and oral hygienists, in particular, will be asked to observe two images of all the 22 subjects, i.e. after treatment with A or B mouthwash, and to answer to the question: "Which picture shows the most pigmented teeth?" Possible answers will be: "A, or B or no difference between the two images". Pigmentation will be also quantified using the numeric scale (0= no pigmentation to 10=strong pigmentation).

The observer will be not instructed in how the color of the teeth should appear in case of CHX pigmentation.

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Official Title:
Efficacy of an Anti-Discoloration System (ADS) to Reduce Dental Staining in a 0.12% Chlorhexidine-based Mouthwash
Study Start Date :
Dec 1, 2011
Actual Primary Completion Date :
Feb 1, 2012
Actual Study Completion Date :
Jul 1, 2012

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Chlorhexidine gluconate with ADS

Chlorhexidine 0.12% plus Anti-Discoloration System Mouthwash

Drug: Chlorhexidine gluconate with ADS
Oral rinsing, twice a day, for 21 days
Other Names:
  • Curasept (0.12% Chlorhexidine gluconate with ADS)
  • Active Comparator: Chlorhexidine gluconate without ADS

    Chlorhexidine 0.12% Mouthwash

    Drug: Chlorhexidine gluconate without ADS
    Oral rinsing, twice a day, for 21 days
    Other Names:
  • Dentosan (0.12% Chlorhexidine gluconate without ADS)
  • Outcome Measures

    Primary Outcome Measures

    1. Dental Staining - spectroscopic evaluation [21 days]

      dental color before and after the two treatments

    Secondary Outcome Measures

    1. Dental Staining - visual evaluation [21 days]

      dental color before and after the two treatments

    2. Dental Staining - visual evaluation on images [21 days of treatments, re-analysis of images after 6 months from the end of the trial]

      dental color before and after the two treatments

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 40 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • to be free from oral mucosa conditions affecting its integrity

    • to avoid drug or mouthwash intake during the study and in the previous month

    Exclusion Criteria:
    • specific allergy to mouthrinses

    • presence of periodontitis

    • frequent use of Chlorhexidine-based oral hygiene products

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Milan Milano Italy 20142

    Sponsors and Collaborators

    • University of Milan

    Investigators

    • Principal Investigator: Antonio Carrassi, MD, University of Milan

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    ANDREA SARDELLA, Associate Professor, University of Milan
    ClinicalTrials.gov Identifier:
    NCT02709824
    Other Study ID Numbers:
    • ADS2012
    First Posted:
    Mar 16, 2016
    Last Update Posted:
    Mar 22, 2016
    Last Verified:
    Mar 1, 2016
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Mar 22, 2016